Polascik TJ - Search Results

1

Multivariate models as predictors of pathological stage using Gleason score, clinical stage, and serum prostate-specific antigen.

Polascik TJ, Pearson JD, Partin AW. Polascik TJ, et al. Semin Urol Oncol. 1998 Aug;16(3):160-71. Semin Urol Oncol. 1998. PMID: 9741421

2

Partial nephrectomy: technique, complications and pathological findings.

Polascik TJ, Pound CR, Meng MV, Partin AW, Marshall FF. Polascik TJ, et al. J Urol. 1995 Oct;154(4):1312-8. doi: 10.1016/s0022-5347(01)66845-9. J Urol. 1995. PMID: 7658526 Free article. Review.

3

Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis.

Polascik TJ, Pound CR, DeWeese TL, Walsh PC. Polascik TJ, et al. Urology. 1998 Jun;51(6):884-9; discussion 889-90. Urology. 1998. PMID: 9609622 Free article. Review.

4

Frequent occurrence of metastatic disease in patients with renal cell carcinoma and intrahepatic or supradiaphragmatic intracaval extension treated with surgery: an outcome analysis.

Polascik TJ, Partin AW, Pound CR, Marshall FF. Polascik TJ, et al. Urology. 1998 Dec;52(6):995-9. doi: 10.1016/s0090-4295(98)00367-7. Urology. 1998. PMID: 9836543 Free article.

5

Ablation of renal tumors in a rabbit model with interstitial saline-augmented radiofrequency energy: preliminary report of a new technology.

Polascik TJ, Hamper U, Lee BR, Dai Y, Hilton J, Magee CA, Crone JK, Shue MJ, Ferrell M, Trapanotto V, Adiletta M, Partin AW. Polascik TJ, et al. Urology. 1999 Mar;53(3):465-72; discussion 470-2. doi: 10.1016/s0090-4295(98)00651-7. Urology. 1999. PMID: 10096368 Free article.

6

Comparison of clinical staging algorithms and 111indium-capromab pendetide immunoscintigraphy in the prediction of lymph node involvement in high risk prostate carcinoma patients.

Polascik TJ, Manyak MJ, Haseman MK, Gurganus RT, Rogers B, Maguire RT, Partin AW. Polascik TJ, et al. Cancer. 1999 Apr 1;85(7):1586-92. Cancer. 1999. PMID: 10193950 Clinical Trial.

7

Prostate specific antigen: a decade of discovery--what we have learned and where we are going.

Polascik TJ, Oesterling JE, Partin AW. Polascik TJ, et al. J Urol. 1999 Aug;162(2):293-306. doi: 10.1016/s0022-5347(05)68543-6. J Urol. 1999. PMID: 10411025 Review.

8

Influence of sextant prostate needle biopsy or surgery on the detection and harvest of intact circulating prostate cancer cells.

Polascik TJ, Wang ZP, Shue M, Di S, Gurganus RT, Hortopan SC, Ts'o PO, Partin AW. Polascik TJ, et al. J Urol. 1999 Sep;162(3 Pt 1):749-52. doi: 10.1097/00005392-199909010-00034. J Urol. 1999. PMID: 10458358 Free article.

9

Clinical utility of indium 111-capromab pendetide immunoscintigraphy in the detection of early, recurrent prostate carcinoma after radical prostatectomy.

Raj GV, Partin AW, Polascik TJ. Raj GV, et al. Among authors: polascik tj. Cancer. 2002 Feb 15;94(4):987-96. Cancer. 2002. PMID: 11920467 Free article.

10

Use of multivariate models to improve prediction of pathologic stage for men with clinically localized prostate cancer.

Polascik TJ, Pearson JD, Partin AW, Polascik DT. Polascik TJ, et al. Among authors: polascik dt. Prostate Cancer Prostatic Dis. 1998 Dec;1(6):301-306. doi: 10.1038/sj.pcan.4500258. Prostate Cancer Prostatic Dis. 1998. PMID: 12496871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

359 results

Search Page

Filters